Reviva Pharmaceuticals Holdings, Inc. (RVPH)
OTCMKTS · Delayed Price · Currency is USD
0.5510
-0.0333 (-5.70%)
At close: Jul 16, 2026
RVPH Market Cap
RVPH has a market cap or net worth of $7.22 million as of July 17, 2026. Its market cap has decreased by -72.73% in one year.
Market Cap
7.22M
Enterprise Value
-14.74M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.55
ChartMarket Cap Chart
Since October 18, 2018, RVPH's market cap has decreased from 25.21M to 7.22M, a decrease of -71.35%. That is a compound annual growth rate of -14.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 7.22M | -77.84% |
| Dec 31, 2025 | 32.60M | -61.33% |
| Dec 31, 2024 | 84.31M | -41.36% |
| Dec 29, 2023 | 143.78M | 65.49% |
| Dec 30, 2022 | 86.88M | 115.01% |
| Dec 31, 2021 | 40.41M | -49.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nymox Pharmaceutical | 12.60M |
| LianBio | 11.96M |
| Brainstorm Cell Therapeutics | 10.59M |
| Zenith Capital | 8.79M |
| Adaptimmune Therapeutics | 8.75M |
| Synlogic | 8.32M |
| NKGen Biotech | 7.84M |
| Biomind Labs | 7.76M |